Recent Company News

• 09:15 AM ET Jun 26, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:17 AM ET Jun 26, 2025
  

  StreetAccount Summary - US Pre-market trading

• 02:05 PM ET Jun 25, 2025
  

  FDA grants 510(k) clearance for Grifols' Erytra Eflexis (€9.94, 0.00)

• 03:09 AM ET Jun 24, 2025
  

  Grifols paid up to 39% more to buy plasma from family-linked firm Scranton - Bloomberg (post EU close 23-Jun) (€10.13, 0.00)

• 01:14 PM ET Jun 11, 2025
  

  Grifols successfully completes Biotest delisting (€10.47, 0.00)

• 07:03 AM ET May 13, 2025
  

  Street Takeaways - Grifols Q1 Earnings (€8.96, +0.57)

• 04:56 AM ET May 13, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:54 AM ET May 13, 2025
  

  StreetAccount Summary - European pre-market trading update

• 12:13 PM ET May 12, 2025
  

  StreetAccount Metrics Recap - Grifols Q1 Earnings (€8.39, 0.00)

• 12:12 PM ET May 12, 2025
  

  Grifols reports Q1 net income €60M vs FactSet €48.0M [6 est, €35-83.5M] (€8.39, 0.00)